AzTrials
AzTrials

Hip FractureNCT04285333

Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block for Hip Fracture

A study testing fascia iliaca block and percapsular nerve group block in people with Hip Fracture and Analgesia, run by University Tunis El Manar at 1 site in Tunisia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Spinal anesthesia (SA) is a widely accepted anesthetic technique for hip fracture repair among elderly. Positioning for SA can be extremely painful. Effective management of pain is important for these patients comfort. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hip Fracture, Analgesia, Acute Pain
What is being tested?
fascia iliaca block and percapsular nerve group block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteTunisia
Study dates
17 Mar 2020to 31 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • - Patients aged ≥ 65 years old and undergoing hip fracture surgical repair under continuous spinal anesthesia (CSA).
  • Patients for whom pain was felt when raising the affected limb to 15 degrees (VERBAL PAIN SCALE =2)

Who cannot join

  • - ASA physical status ≥ 4.
  • Impaired cognition or Dementia.
  • Multiple fractures.
  • Contraindication to regional anesthesia.
  • Patient's disapproval.

Trial locations and contacts

1 site in 1 country.

Tunisia1 site
  • Institut Kassab D'Orthopedie

    Tunis, 2010

Other trials in Tunisia

About this study

Official title: Analgesic Techniques Before Spinal Anesthesia for Hip Fracture Repair: Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block

Spinal anesthesia (SA) is a widely accepted anesthetic technique for hip fracture repair among elderly. Positioning for SA can be extremely painful. Effective management of pain is important for these patients comfort.

Fascia Iliaca block (FIB) and Femoral nerve blocks are commonly used for analgesia in hip fracture patients. However, they often provide a modest reduction in pain.

Read more

The Percapsular Nerve Group block (PENG Block) has the advantage that it covers the accessory obturator nerve.

Aim of the study: compare FIB with PENG prior to positioning hip fracture patients for standardized SA.

In a prospective randomized double blind we included 80 patients aged more than 65 years old, for whom pain was felt when raising the affected limb to 15 degrees. Patients were assigned to receive either ultrasound guided Fascia Iliaca block or Percapsular Nerve Group block using 20 mL Lidocaine 1.5% in both groups. We compared pain on positioning for spinal anesthesia using Verbal Rating Scale (VRS 0 = no pain , VRS 1 = mild pain, t 2= severe pain) for both groups. We also recorded different times to perfom block.

Read the detailed description

The purpose of the study was to compare analgesis effect of Percapsula nerve group block to fascia iliaca block prior to positioning hip fracture patients for standardized SA. We included 80 patients reporting pain with Verbal Rating Scale at 2 when raising the affected limb to 15 degrees. All patients admitted to induction room, were given standard monitoring and we randomized to receive either: ultrasound fascia iliaca block using linear high frequency ultrasound probe (10-15MHz) placed in a transverse direction over the anterior thigh below the inguinal ligament. A 50 mm needle was advanced until the tips placed underneath the fascia iliaca and 20 mL 1.5% Lidocaine was injected or ultrasound Percapsula nerve group block A curvilinear using low-frequency ultrasound probe (2-5MHz) that was initially placed in a transverse plane over the anterior inferior iliac spine and then aligned with the pubic ramus by rotating the probe counter clockwise approximately 45 degrees. In this view, the iliopubic eminence , the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle were observed and than a 100 mm needle was advanced to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly and 20 mL 1.5% Lidocaine.We compared pain on positioning for spinal anesthesia and also different time to realise both blocks.

Being tested
fascia iliaca block, percapsular nerve group block
Keywords
hip fracture, nerve block, spinal anesthesia, analgesia
Medical subject headings
Hip Fractures, Agnosia, Acute Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fascia iliaca blockProcedure or surgery

    Also called BIF for hip fracture

    ultrasound guided block with 20 mL lidocaine 1.5%

  • percapsular nerve group blockProcedure or surgery

    Also called PENG block for hip fracture

    ultrasound guided block with 20 mL lidocaine 1.5%

Study groups in NCT04285333
Study groupRoleWhat they receive
fascial iliacaActive comparator: A linear high frequency ultrasound probe (10-15MHz) was placed in a transverse direction over the anterior thigh below the inguinal ligament. We identified the femoral artery and the iliacus muscle lateral to it, covered by the fascia iliaca. The needle was inserted in plane and a 22 gauge, 50 mm needle was advanced until the tips placed underneath the fascia iliaca. Following negative aspiration, the local anesthetic solution was injected in 5mL increments while observing for adequate fluid spread in this plane for a total volume of 20 mL of 1.5% Lidocaine
Receives: Procedure: fascia iliaca block
Percapsular nerve group blockExperimentalA curvilinear low-frequency ultrasound probe (2-5MHz) was initially placed in a transverse plane over the anterior inferior iliac spine (AIIS) and then aligned with the pubic ramus by rotating the probe counterclockwise approximately 45 degrees. In this view, the iliopubic eminence (IPE), the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle were observed. A 22-gauge, 100-mm needle was inserted from lateral to medial in an in-plane approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. Following negative aspiration, the local anesthetic solution was injected in 5 mL increments while observing for adequate fluid spread in this plane for a total volume of 20 mL of 1.5% Lidocaine.
Receives: Procedure: percapsular nerve group block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. positioning pain

    Verbal Rating Scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 30 minutes

Secondary outcomes (9)
  1. Positioning Rating

    verbal rating scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 40 minutes

  2. Imaging time

    For the PENG block:the femoral artery, the anterior inferior iliac spine, the iliopubic eminence and the psoas tendon.

    For the FIB: the femoral artery, the iliacus muscle, the fascia iliaca and the fascia lata.

    Measured: up to 10 minutes

  3. Puncture time

    the time that stretches from the introduction of the needle until the end of the injection of local anesthetic

    Measured: up to 10 minutes

  4. Performance time

    the imaging time + time to puncture.

    Measured: up to 10 minutes

  5. Number of punctures

    the number of redirection of the needle after removing 2 cm.

    Measured: up to 10 minutes

  6. pain 5 after block

    verbal rating scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 5 minutes

  7. pain 10 after block

    verbal rating scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 10 minutes

  8. pain 15 after block

    verbal rating scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 15 minutes

  9. pain 20 after block

    verbal rating scale (VRS) [0=no pain ; 4=worst pain]

    Measured: up to 20 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2020
  2. Study start17 Mar 2020
  3. Primary completion30 Apr 2020
  4. Study completion31 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomised single blinded study
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04285333
Sponsor's protocol ID
CE-IMKO 102/2019
Status last verified
Feb 2024
First submitted
9 Feb 2020
Last updated
13 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing fascia iliaca block and percapsular nerve group block in people with Hip Fracture and Analgesia, run by University Tunis El Manar at 1 site in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

positioning pain (time frame: up to 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in